Target intelligence / Profile preview

DNA-directed RNA polymerase beta subunit, bacterial type (RNAP β subunit)

Target
RNAP β subunit
Molecular classification
Enzyme, Transcription factor (component of multi-subunit RNA polymerase)
01

Overview

The DNA-directed RNA polymerase beta subunit is the second-largest subunit of the bacterial multisubunit RNA polymerase core enzyme and is encoded by the rpoB gene. Together with the β′ subunit, it forms the catalytic center essential for RNA synthesis from DNA templates. The β subunit plays a key role in binding nucleotides, catalyzing phosphodiester bond formation, and interacting with DNA and nascent RNA during transcription. This subunit is a well-established antimicrobial target, as several clinically important antibiotics (such as rifampicin) inhibit bacterial RNA polymerase by binding to the β subunit and preventing transcription, particularly in pathogens like Mycobacterium tuberculosis. Mutations in the β subunit can confer drug resistance, making it a molecular biomarker for antibiotic susceptibility testing and treatment monitoring[2][3][4][7].

Other names
Bacterial RNA polymerase β subunitRNA polymerase subunit β (rpoB gene product)RNAP βDNA-dependent RNA polymerase β subunit
02

Mechanism of action

Inhibition of RNA synthesis by binding the β subunit and blocking transcription elongation Allosteric inhibition of the RNA polymerase catalytic site

03

Biological functions

Transcription (RNA synthesis)Gene expression regulation
04

Disease associations

Infection (target for antibacterial drugs)
05

Safety considerations

Development of drug resistance due to rpoB mutationsOff-target effects if drugs are insufficiently selective for bacterial versus human RNA polymerases
06

Interacting drugs

Rifampicin

4 more in the full profile.

07

Biomarkers

Mutations in the rpoB gene (used as a biomarker for rifampicin resistance in Mycobacterium tuberculosis and other bacteria)

Beyond the preview

Go deeper on DNA-directed RNA polymerase beta subunit, bacterial type (RNAP β subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA-directed RNA polymerase beta subunit, bacterial type (RNAP β subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call